Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$790.23
+0.4%
$767.03
$677.09
$972.53
$745.79B0.43.66 million shs3.13 million shs
McDonald's Corporation stock logo
MCD
McDonald's
$298.60
+1.9%
$304.35
$246.12
$326.32
$209.52B0.533.52 million shs5.36 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$71.06
+2.0%
$70.36
$57.00
$143.49
$311.17B0.647.28 million shs6.37 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+0.41%+1.36%-2.17%+8.01%-15.93%
McDonald's Corporation stock logo
MCD
McDonald's
+1.80%+1.63%-0.55%-3.63%+19.23%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+1.80%+2.90%-10.50%+9.73%-50.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.9817 of 5 stars
4.44.03.34.02.91.71.9
McDonald's Corporation stock logo
MCD
McDonald's
4.8362 of 5 stars
2.25.04.21.13.82.52.5
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4.7924 of 5 stars
4.15.02.50.03.50.03.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.75
Moderate Buy$1,012.2228.09% Upside
McDonald's Corporation stock logo
MCD
McDonald's
2.45
Hold$322.297.93% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.27
Hold$112.0057.62% Upside

Current Analyst Ratings Breakdown

Latest MCD, NVO, and LLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$1,133.00 ➝ $1,135.00
7/10/2025
McDonald's Corporation stock logo
MCD
McDonald's
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$345.00
7/9/2025
McDonald's Corporation stock logo
MCD
McDonald's
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$364.00 ➝ $365.00
7/9/2025
McDonald's Corporation stock logo
MCD
McDonald's
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$350.00 ➝ $356.00
6/30/2025
McDonald's Corporation stock logo
MCD
McDonald's
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$340.00 ➝ $325.00
6/20/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$936.00
6/13/2025
McDonald's Corporation stock logo
MCD
McDonald's
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
6/10/2025
McDonald's Corporation stock logo
MCD
McDonald's
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Sell$319.00 ➝ $260.00
6/9/2025
McDonald's Corporation stock logo
MCD
McDonald's
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$329.00 ➝ $324.00
6/6/2025
McDonald's Corporation stock logo
MCD
McDonald's
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$346.00 ➝ $315.00
6/5/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$45.04B16.63$14.29 per share55.28$15.03 per share52.58
McDonald's Corporation stock logo
MCD
McDonald's
$25.92B8.24$15.01 per share19.89($5.30) per share-56.34
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$42.12B7.53$3.98 per share17.86$4.66 per share15.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$10.59B$12.2964.3025.391.1522.67%85.51%15.74%8/7/2025 (Estimated)
McDonald's Corporation stock logo
MCD
McDonald's
$8.22B$11.3326.3622.523.0631.75%-195.27%15.21%8/6/2025 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$14.64B$3.3821.0215.251.3634.52%80.94%24.23%8/6/2025 (Estimated)

Latest MCD, NVO, and LLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.56N/AN/AN/A$14.40 billionN/A
8/6/2025Q2 2025
McDonald's Corporation stock logo
MCD
McDonald's
$3.14N/AN/AN/A$6.68 billionN/A
8/6/2025Q2 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.89N/AN/AN/A$77.51 billionN/A
5/7/2025Q1 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.92$0.92N/A$0.92N/A$11.87 billion
5/1/2025Q1 2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$4.64$3.34-$1.30$3.06$12.77 billion$12.73 billion
5/1/2025Q1 2025
McDonald's Corporation stock logo
MCD
McDonald's
$2.67$2.67N/A$2.60$6.17 billion$5.96 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.000.76%N/A48.82%11 Years
McDonald's Corporation stock logo
MCD
McDonald's
$7.082.37%N/A62.49%49 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.642.31%N/A48.52%N/A

Latest MCD, NVO, and LLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/23/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.500.78%8/15/20258/15/20259/10/2025
5/20/2025
McDonald's Corporation stock logo
MCD
McDonald's
quarterly$1.772.22%6/2/20256/2/20256/16/2025
5/5/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.500.73%5/16/20255/16/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.18
1.37
1.06
McDonald's Corporation stock logo
MCD
McDonald's
N/A
1.18
1.17
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.70
0.74
0.56

Institutional Ownership

CompanyInstitutional Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
McDonald's Corporation stock logo
MCD
McDonald's
70.29%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.13%
McDonald's Corporation stock logo
MCD
McDonald's
0.25%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
47,000947.74 million946.50 millionOptionable
McDonald's Corporation stock logo
MCD
McDonald's
150,000715.03 million713.25 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
77,3494.47 billion4.46 billionOptionable

Recent News About These Companies

Novo Nordisk: Reclaiming Market Share
TD Cowen Keeps Buy on Novo Nordisk (NVO)
Novo Nordisk A/S (NYSE:NVO) Shares Up 1.6% - Still a Buy?
Novo Nordisk Seeks EU Approval for Higher Wegovy Dose

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$790.22 +3.31 (+0.42%)
Closing price 07/10/2025 03:59 PM Eastern
Extended Trading
$788.48 -1.75 (-0.22%)
As of 06:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

McDonald's stock logo

McDonald's NYSE:MCD

$298.60 +5.58 (+1.90%)
Closing price 07/10/2025 03:59 PM Eastern
Extended Trading
$297.83 -0.77 (-0.26%)
As of 06:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$71.06 +1.37 (+1.96%)
Closing price 07/10/2025 03:59 PM Eastern
Extended Trading
$70.44 -0.62 (-0.87%)
As of 06:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.